Nordstedt C, Kvanta A, Fredholm B B
Department of Pharmacology, Karolinska Institutet, Stockholm, Sweden.
Biochem Biophys Res Commun. 1988 Dec 30;157(3):1046-50. doi: 10.1016/s0006-291x(88)80980-x.
The regulation of prostaglandin stimulated cAMP accumulation in cells of the human T-cell leukemia line Jurkat was examined. Pretreatment with PGE2 (0.1-10 nM) for 2 hour caused a concentration dependent desensitization of the prostaglandin receptor. Tumor promoting phorbol esters (1-1000 nM) could also inhibit PGE2 stimulated cAMP production dose dependently. Inhibition of tubulin polymerization with colchicine or nocodazole (1 microM) eliminated prostaglandin but not phorbol ester induced desensitization of the receptor. It is concluded that agonist and phorbol ester induced desensitization are mediated by two distinct mechanisms and that tubulin polymerization appear to be required only for agonist induced desensitization of the prostaglandin receptor.
研究了前列腺素刺激人T细胞白血病细胞系Jurkat中cAMP积累的调节机制。用PGE2(0.1 - 10 nM)预处理2小时可导致前列腺素受体浓度依赖性脱敏。促肿瘤佛波酯(1 - 1000 nM)也能剂量依赖性地抑制PGE2刺激的cAMP产生。用秋水仙碱或诺考达唑(1 microM)抑制微管蛋白聚合可消除前列腺素诱导的受体脱敏,但不能消除佛波酯诱导的受体脱敏。结论是激动剂和佛波酯诱导的脱敏由两种不同机制介导,微管蛋白聚合似乎仅对激动剂诱导的前列腺素受体脱敏是必需的。